Amgen Inc. (AMGN) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NasdaqGS. Market cap 220.28B USD. 52-week range 288.00 to 447.03 USD. Trailing P/E 25.3. Data as of 2026-10-09.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of ...